Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1988 4
1989 1
1990 2
1991 4
1992 1
1993 5
1994 2
1995 1
1997 5
1998 2
1999 1
2000 5
2001 1
2002 5
2003 7
2004 6
2005 6
2006 3
2007 7
2008 9
2009 5
2010 1
2011 2
2012 5
2013 2
2014 8
2015 18
2016 17
2017 14
2018 15
2019 18
2020 25
Text availability
Article attribute
Article type
Publication date

Search Results

179 results
Results by year
Filters applied: . Clear all The following terms were not found in PubMed: 03c458618ac11a6c0587df48efb5b884bc27092dbf64c9bd8483175d8c8cdf50, 20EJ, 03c458618ac11a6c0587df48efb5b884bc27092dbf64c9bd8483175d8c8cdf50, 5BAuthor, 03c458618ac11a6c0587df48efb5b884bc27092dbf64c9bd8483175d8c8cdf50
Page 1
Role of neutrophils in allergic asthma.
Radermecker C, Louis R, Bureau F, Marichal T. Radermecker C, et al. Curr Opin Immunol. 2018 Oct;54:28-34. doi: 10.1016/j.coi.2018.05.006. Epub 2018 Jun 6. Curr Opin Immunol. 2018. PMID: 29883877 Free article. Review.
The effect of emicizumab prophylaxis on health-related outcomes in persons with haemophilia A with inhibitors: HAVEN 1 Study.
Oldenburg J, Mahlangu JN, Bujan W, Trask P, Callaghan MU, Young G, Asikanius E, Peyvandi F, Santagostino E, Kruse-Jarres R, Negrier C, Kessler C, Xu J, Windyga J, Shima M, von Mackensen S. Oldenburg J, et al. Haemophilia. 2019 Jan;25(1):33-44. doi: 10.1111/hae.13618. Epub 2018 Nov 14. Haemophilia. 2019. PMID: 30427582 Free article. Clinical Trial.
Health-related outcomes assessed at baseline and monthly thereafter: Haemophilia Quality of Life Questionnaire for Adults (Haem-A-QoL), Haemophilia-specific Quality of Life Questionnaire for Children Short Form (Haemo-QoL SF), EuroQol 5-Dimensions 5-Levels (EQ-5D-5L) index …
Health-related outcomes assessed at baseline and monthly thereafter: Haemophilia Quality of Life Questionnaire for Adults (Haem-A-QoL), Haem …
Early Palliative Care Consultation in the Medical ICU: A Cluster Randomized Crossover Trial.
Ma J, Chi S, Buettner B, Pollard K, Muir M, Kolekar C, Al-Hammadi N, Chen L, Kollef M, Dans M. Ma J, et al. Crit Care Med. 2019 Dec;47(12):1707-1715. doi: 10.1097/CCM.0000000000004016. Crit Care Med. 2019. PMID: 31609772 Clinical Trial.
Patient-reported quality of life after tisagenlecleucel infusion in children and young adults with relapsed or refractory B-cell acute lymphoblastic leukaemia: a global, single-arm, phase 2 trial.
Laetsch TW, Myers GD, Baruchel A, Dietz AC, Pulsipher MA, Bittencourt H, Buechner J, De Moerloose B, Davis KL, Nemecek E, Driscoll T, Mechinaud F, Boissel N, Rives S, Bader P, Peters C, Sabnis HS, Grupp SA, Yanik GA, Hiramatsu H, Stefanski HE, Rasouliyan L, Yi L, Shah S, Zhang J, Harris AC. Laetsch TW, et al. Lancet Oncol. 2019 Dec;20(12):1710-1718. doi: 10.1016/S1470-2045(19)30493-0. Epub 2019 Oct 9. Lancet Oncol. 2019. PMID: 31606419 Free PMC article. Clinical Trial.
A prespecified secondary endpoint, reported here, was patient-reported quality of life measured with the Pediatric Quality of Life Inventory (PedsQL) and European Quality of Life-5 Dimensions questionnaire (EQ-5D). Patients completed the questionnaires at baseline, day 28, …
A prespecified secondary endpoint, reported here, was patient-reported quality of life measured with the Pediatric Quality of Life Inventory …
Estimating minimal clinically important differences of upper-extremity measures early after stroke.
Lang CE, Edwards DF, Birkenmeier RL, Dromerick AW. Lang CE, et al. Arch Phys Med Rehabil. 2008 Sep;89(9):1693-700. doi: 10.1016/j.apmr.2008.02.022. Arch Phys Med Rehabil. 2008. PMID: 18760153 Free PMC article. Clinical Trial.
Subjects were tested at the prerandomization baseline assessment (average days poststroke, 9.5d) and the first posttreatment assessment (average days poststroke, 25.9d). ...
Subjects were tested at the prerandomization baseline assessment (average days poststroke, 9.5d) and the first posttreatment assessme …
Comparison of robotics, functional electrical stimulation, and motor learning methods for treatment of persistent upper extremity dysfunction after stroke: a randomized controlled trial.
McCabe J, Monkiewicz M, Holcomb J, Pundik S, Daly JJ. McCabe J, et al. Arch Phys Med Rehabil. 2015 Jun;96(6):981-90. doi: 10.1016/j.apmr.2014.10.022. Epub 2014 Nov 15. Arch Phys Med Rehabil. 2015. PMID: 25461822 Free article. Clinical Trial.
PARTICIPANTS: Enrolled subjects (N=39) were >1 year postsingle stroke (attrition rate=10%; 35 completed the study). INTERVENTIONS: All groups received treatment 5d/wk for 5h/d (60 sessions), with unique treatment as follows: ML alone (n=11) (5h/d partial- and whole-task …
PARTICIPANTS: Enrolled subjects (N=39) were >1 year postsingle stroke (attrition rate=10%; 35 completed the study). INTERVENTIONS: All gr …
Quality of Life Outcomes for Cabozantinib Versus Everolimus in Patients With Metastatic Renal Cell Carcinoma: METEOR Phase III Randomized Trial.
Cella D, Escudier B, Tannir NM, Powles T, Donskov F, Peltola K, Schmidinger M, Heng DYC, Mainwaring PN, Hammers HJ, Lee JL, Roth BJ, Marteau F, Williams P, Baer J, Mangeshkar M, Scheffold C, Hutson TE, Pal S, Motzer RJ, Choueiri TK. Cella D, et al. J Clin Oncol. 2018 Mar 10;36(8):757-764. doi: 10.1200/JCO.2017.75.2170. Epub 2018 Jan 29. J Clin Oncol. 2018. PMID: 29377755 Free PMC article. Clinical Trial.
Patients and Methods Patients completed the 19-item Functional Assessment of Cancer Therapy-Kidney Symptom Index (FKSI-19) and the five-level EuroQol (EQ-5D-5L) questionnaires at baseline and throughout the study. The nine-item FKSI-Disease-Related Symptoms (FKSI-DRS), a s …
Patients and Methods Patients completed the 19-item Functional Assessment of Cancer Therapy-Kidney Symptom Index (FKSI-19) and the five-leve …
A simplified frailty scale predicts outcomes in transplant-ineligible patients with newly diagnosed multiple myeloma treated in the FIRST (MM-020) trial.
Facon T, Dimopoulos MA, Meuleman N, Belch A, Mohty M, Chen WM, Kim K, Zamagni E, Rodriguez-Otero P, Renwick W, Rose C, Tempescul A, Boyle E, Manier S, Attal M, Moreau P, Macro M, Leleu X, Lorraine Chretien M, Ludwig H, Guo S, Sturniolo M, Tinel A, Silvia Monzini M, Costa B, Houck V, Hulin C, Yves Mary J. Facon T, et al. Leukemia. 2020 Jan;34(1):224-233. doi: 10.1038/s41375-019-0539-0. Epub 2019 Aug 19. Leukemia. 2020. PMID: 31427722 Free PMC article. Clinical Trial.
Patients from the large, phase 3 FIRST trial in newly diagnosed multiple myeloma (NDMM) were retrospectively investigated to determine outcomes based on frailty using scores for age, Charlson Comorbidity Index (CCI), and Eastern Cooperative Oncology Group performance status (ECOG …
Patients from the large, phase 3 FIRST trial in newly diagnosed multiple myeloma (NDMM) were retrospectively investigated to determine outco …
Health Status After Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis.
Baron SJ, Magnuson EA, Lu M, Wang K, Chinnakondepalli K, Mack M, Thourani VH, Kodali S, Makkar R, Herrmann HC, Kapadia S, Babaliaros V, Williams MR, Kereiakes D, Zajarias A, Alu MC, Webb JG, Smith CR, Leon MB, Cohen DJ; PARTNER 3 Investigators. Baron SJ, et al. J Am Coll Cardiol. 2019 Dec 10;74(23):2833-2842. doi: 10.1016/j.jacc.2019.09.007. Epub 2019 Sep 29. J Am Coll Cardiol. 2019. PMID: 31577923 Clinical Trial.
Health status was assessed at baseline and 1, 6, and 12 months using the KCCQ (Kansas City Cardiomyopathy Questionnaire), SF-36 (Short Form-36 Health Survey), and EQ-5D (EuroQoL). The primary endpoint was change in KCCQ-OS (KCCQ Overall Summary) score over time. ...
Health status was assessed at baseline and 1, 6, and 12 months using the KCCQ (Kansas City Cardiomyopathy Questionnaire), SF-36 (Short Form- …
Long-term evolution of patient-reported outcome measures in spinocerebellar ataxias.
Jacobi H, du Montcel ST, Bauer P, Giunti P, Cook A, Labrum R, Parkinson MH, Durr A, Brice A, Charles P, Marelli C, Mariotti C, Nanetti L, Sarro L, Rakowicz M, Sulek A, Sobanska A, Schmitz-Hübsch T, Schöls L, Hengel H, Baliko L, Melegh B, Filla A, Antenora A, Infante J, Berciano J, van de Warrenburg BP, Timmann D, Szymanski S, Boesch S, Nachbauer W, Kang JS, Pandolfo M, Schulz JB, Melac AT, Diallo A, Klockgether T. Jacobi H, et al. J Neurol. 2018 Sep;265(9):2040-2051. doi: 10.1007/s00415-018-8954-0. Epub 2018 Jun 29. J Neurol. 2018. PMID: 29959555
METHODS: To assess the functional capacity in daily living, we used the functional assessment (part IV) of the Unified Huntington's Disease Rating Scale (UHDRS-IV), for health-related quality of life the visual analogue scale of the EuroQol Five Dimensions Questionnaire (EQ-5D
METHODS: To assess the functional capacity in daily living, we used the functional assessment (part IV) of the Unified Huntington's Disease …
179 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback